Wakeley M, Armstead B, Gray C, Tindal E, Heffernan D, Chung C, et al. Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression. Front Med (Lausanne). 2023;10:1176602 pubmed publisher

Ayass M, Tripathi T, Griko N, Pashkov V, Dai J, Zhang J, et al. Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease. Virol J. 2022;19:227 pubmed publisher

Cangkrama M, Liu H, Whipman J, Zubair M, Matsushita M, Di Filippo M, et al. A Protumorigenic mDia2-MIRO1 Axis Controls Mitochondrial Positioning and Function in Cancer-Associated Fibroblasts. Cancer Res. 2022;82:3701-3717 pubmed publisher

Cakir C, Nayci A, Ferlengez E, Guler M, Idiz U. Cytokines the Etiology of Idiopathic Granulomatous Mastitis. J Coll Physicians Surg Pak. 2022;32:869-873 pubmed publisher

Idiz U, Yurttas T, Degirmencioglu S, Orhan B, Erdoğan E, Sevik H, et al. Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients. J Med Virol. 2022;94:4744-4753 pubmed publisher

Chauss D, Freiwald T, McGregor R, Yan B, Wang L, Nova Lamperti E, et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nat Immunol. 2022;23:62-74 pubmed publisher

Syrimi E, Fennell E, Richter A, Vrljicak P, Stark R, Ott S, et al. The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery. iScience. 2021;24:103215 pubmed publisher

Duan F, Guo L, Yang L, Han Y, Thakur A, Nilsson Payant B, et al. Modeling COVID-19 with Human Pluripotent Stem Cell-Derived Cells Reveals Synergistic Effects of Anti-inflammatory Macrophages with ACE2 Inhibition Against SARS-CoV-2. Res Sq. 2020;: pubmed publisher

McGregor R, Chauss D, Freiwald T, Yan B, Wang L, Nova Lamperti E, et al. An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19. bioRxiv. 2020;: pubmed publisher

Mei Q, Zhang W, Liu Y, Yang Q, Rasko J, Nie J, et al. Camrelizumab Plus Gemcitabine, Vinorelbine, and Pegylated Liposomal Doxorubicin in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma: A Single-Arm, Open-Label, Phase II Trial. Clin Cancer Res. 2020;26:4521-4530 pubmed publisher